Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers
David F Grabski, Aakrosh Ratan, Laurie R Gray, Stefan Bekiranov, David Rekosh, Marie-Louise Hammarskjold, Sara K Rasmussen
doi: https://doi.org/10.1101/2020.02.28.20026260
David F Grabski
1Department of Surgery, University of Virginia School of Medicine
2Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia
Aakrosh Ratan
3Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine
Laurie R Gray
2Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia
4Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine
Stefan Bekiranov
5Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine
David Rekosh
2Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia
3Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine
Marie-Louise Hammarskjold
2Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia
3Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine
Sara K Rasmussen
2Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia
6Division of Pediatric Surgery, Department of Surgery, University of Virginia School of Medicine
Data Availability
Data is publicly available.
Posted March 03, 2020.
Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers
David F Grabski, Aakrosh Ratan, Laurie R Gray, Stefan Bekiranov, David Rekosh, Marie-Louise Hammarskjold, Sara K Rasmussen
medRxiv 2020.02.28.20026260; doi: https://doi.org/10.1101/2020.02.28.20026260
Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers
David F Grabski, Aakrosh Ratan, Laurie R Gray, Stefan Bekiranov, David Rekosh, Marie-Louise Hammarskjold, Sara K Rasmussen
medRxiv 2020.02.28.20026260; doi: https://doi.org/10.1101/2020.02.28.20026260
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)